Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.

Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:

    Preformulation and pharmaceutical formulation studies
    Pharmaceutical materials selection and characterization
    Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation
    QbD in the form a risk assessment and DoE driven approaches
    Design of dosage forms and drug delivery systems
    Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies
    Drug delivery systems research and quality improvement
    Pharmaceutical regulatory affairs

This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

The journal's audience includes:

    Academic Researchers: Individuals involved in pharmaceutical research and development at universities and colleges.
    Industry Professionals: Experts working in the pharmaceutical industry, including formulation scientists, process engineers and quality assurance specialists.
    Healthcare Practitioners: Medical professionals interested in the latest advancements in drug delivery and pharmaceutical technologies.
    Policy Makers: Regulatory authorities and policy makers who oversee pharmaceutical practices and standards.

All articles received by the Journal will be subject to single-anonymous peer review